Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Herman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The New England Journal of Medicine|December 17, 2020
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
The New England Journal of Medicine|September 29, 2021
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionMeagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
JAMA|January 14, 2022
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Nature|September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular toneMichael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of Allergy and Clinical Immunology|April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptomeWei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The New England Journal of Medicine|December 17, 2020
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
The New England Journal of Medicine|September 29, 2021
REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19David M Weinreich, Sumathi Sivapalasingam, Thomas Norton, et al.
The New England Journal of Medicine|August 4, 2021
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19Meagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination for Covid-19 PreventionMeagan P O'Brien, Eduardo Forleo-Neto, Bret J Musser, et al.
JAMA|January 14, 2022
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical TrialMeagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, et al.
Nature|September 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular toneMichael E Dunn, Aaron Kithcart, Jee Hae Kim, et al.
Pageof 3